rs61549495
Positions:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 1P and 16B. PM4_SupportingBP6_Very_StrongBA1
The NM_018685.5(ANLN):c.883_885dup(p.Ser295dup) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.401 in 1,606,298 control chromosomes in the GnomAD database, including 131,825 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.39 ( 11794 hom., cov: 0)
Exomes 𝑓: 0.40 ( 120031 hom. )
Consequence
ANLN
NM_018685.5 inframe_insertion
NM_018685.5 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.593
Genes affected
ANLN (HGNC:14082): (anillin, actin binding protein) This gene encodes an actin-binding protein that plays a role in cell growth and migration, and in cytokinesis. The encoded protein is thought to regulate actin cytoskeletal dynamics in podocytes, components of the glomerulus. Mutations in this gene are associated with focal segmental glomerulosclerosis 8. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_018685.5. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 7-36407740-A-ACTT is Benign according to our data. Variant chr7-36407740-A-ACTT is described in ClinVar as [Benign]. Clinvar id is 261052.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.567 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANLN | NM_018685.5 | c.883_885dup | p.Ser295dup | inframe_insertion | 5/24 | ENST00000265748.7 | NP_061155.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANLN | ENST00000265748.7 | c.883_885dup | p.Ser295dup | inframe_insertion | 5/24 | 1 | NM_018685.5 | ENSP00000265748 | P2 |
Frequencies
GnomAD3 genomes AF: 0.390 AC: 59157AN: 151578Hom.: 11780 Cov.: 0
GnomAD3 genomes
AF:
AC:
59157
AN:
151578
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.434 AC: 108843AN: 250590Hom.: 24509 AF XY: 0.430 AC XY: 58310AN XY: 135508
GnomAD3 exomes
AF:
AC:
108843
AN:
250590
Hom.:
AF XY:
AC XY:
58310
AN XY:
135508
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.402 AC: 585388AN: 1454602Hom.: 120031 Cov.: 32 AF XY: 0.404 AC XY: 292228AN XY: 724078
GnomAD4 exome
AF:
AC:
585388
AN:
1454602
Hom.:
Cov.:
32
AF XY:
AC XY:
292228
AN XY:
724078
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.390 AC: 59224AN: 151696Hom.: 11794 Cov.: 0 AF XY: 0.393 AC XY: 29103AN XY: 74140
GnomAD4 genome
AF:
AC:
59224
AN:
151696
Hom.:
Cov.:
0
AF XY:
AC XY:
29103
AN XY:
74140
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 04, 2021 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Focal segmental glomerulosclerosis 8 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Dec 05, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at